Blueshift Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Blueshift Asset Management's CRL Position: Q4 2025 in Review
Blueshift Asset Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 1,561 shares — an estimated $244K sold.
Blueshift Asset Management first reported a position in CRL in Q4 2018 and held it in 11 quarters. The position peaked at $5.67M in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q4 2025.
- Blueshift Asset Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
- Blueshift Asset Management sold 1,561 Charles River Laboratories shares in Q4 2025, an estimated $244K.
- Blueshift Asset Management first reported a position in Charles River Laboratories in Q4 2018 and held it in 11 quarters.
- Blueshift Asset Management's Charles River Laboratories position peaked at $5.67M in Q3 2021.
- 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.
Based on Blueshift Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.